Sign in to continue:

Thursday, March 5th, 2026

Red Violet, Inc. 10-K Annual Report: Business Overview, Competitive Strengths, Markets, and Risk Factors (2024)





Red Violet, Inc. 2025 Annual Report: Key Investor Insights

Red Violet, Inc. 2025 Annual Report: Key Investor Insights

Company Overview

Red Violet, Inc. (“Red Violet” or “the Company”) is a technology-driven corporation focused on delivering identity intelligence solutions. The company builds proprietary technologies and analytical capabilities to empower organizations with real-time identification and location services for people, businesses, assets, and their interrelationships. Red Violet’s mission is to make the world safer and reduce the cost of doing business.

Stock and Exchange Information

  • Common Stock, \$0.001 par value per share
  • Trading Symbol: RDVT
  • Listed on: The NASDAQ Stock Market LLC

No securities registered under Section 12(g) of the Exchange Act.

Issuer Status and Reporting

  • Red Violet is NOT a well-known seasoned issuer.
  • The company has filed all required reports and is subject to reporting requirements.
  • Red Violet is classified as a non-accelerated filer and a smaller reporting company. It is NOT an emerging growth company.
  • No restatements or corrections of previously issued financial statements occurred in this report.
  • Not a shell company.

Document Incorporation: Portions of the 2026 Proxy Statement are incorporated by reference for Part III.

Market Overview and Competitive Landscape

Red Violet operates in the rapidly growing data and analytics sector, characterized by technological innovation, frequent product introductions, and evolving industry standards. The company faces competition from both established and emerging data and analytics suppliers. Increased investments and acquisitions by competitors may result in significant price competition, reduced profit margins, or loss of market share. Red Violet acknowledges that there is no assurance it will continue to compete successfully in the future.

The company’s solutions are used in operational and regulated workflows, including advanced analytics and artificial intelligence applications, supporting informed decision-making and risk management. The company’s leading-edge technology platform, extensive identity graph, and dynamic solutions are seen as key competitive strengths.

Seasonality

Results are subject to seasonal fluctuation, with certain products experiencing pressure during Q4. Investors should anticipate potential variation in quarterly performance due to these seasonal trends.

Management Team

  • Derek Dubner – Chief Executive Officer and Chairman
  • James Reilly – President
  • Daniel MacLachlan – Chief Financial Officer
  • Jeff Dell – (Role not specified in excerpt)

The management team is credited with strong performance and significant expertise, supported by decades of collective experience. The company notes the importance of retaining key personnel, as their loss could adversely affect operations and strategic direction.

Key Risks and Price-Sensitive Information

Cybersecurity and Technology Risks

  • Products and services are highly technical and may contain undetected errors, defects, or security vulnerabilities. Errors can be discovered post-release, potentially resulting in revenue loss, customer attrition, or legal claims.
  • Failure to respond to rapid technological changes may lead to loss of customers or product/service obsolescence.
  • Risks associated with artificial intelligence and generative AI: Flawed or erroneous content can harm reputation and financial performance, and may lead to product liability claims.

Legal and Regulatory Risks

  • Changing laws and regulations regarding data collection, maintenance, combination, and use could materially affect operations, requiring costly adaptation and possibly reducing business levels with customers.
  • Company bylaws designate the Delaware Court of Chancery as the sole forum for certain actions, possibly limiting shareholder litigation options.

Business and Operational Risks

  • Uncertainty in future operating results: Profitability depends on generating greater revenue from products and services.
  • Dependence on strategic alliances and joint ventures for growth; failure to develop and maintain these relationships may adversely affect growth.
  • Potential acquisition risks: Integration challenges, unknown liabilities, disruption of existing business, and dilution of shareholders (if stock is used for acquisition).
  • Revenue is concentrated in the U.S. market across a broad range of industries. Economic downturns or volatility in financial markets could reduce demand for services and impact revenue.
  • Macroeconomic factors (credit availability, interest rates, inflation, tariffs, employment levels, consumer confidence, housing demand) significantly influence customer demand and revenue.

Shareholder Information and Accessibility

Principal executive offices: 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431. Telephone: (561) 757-4000.
Corporate website: www.redviolet.com
SEC filings and reports are available free of charge via the “Investors” section of the company’s website and at http://www.sec.gov.

Potentially Price-Sensitive Issues for Investors

  • Red Violet faces increased competition, which could affect market share, pricing, and profitability.
  • Risks associated with technology errors, rapid industry changes, and AI applications may result in financial losses or legal liabilities.
  • Legal and regulatory changes could impose new costs or restrict business activities.
  • Seasonality and macroeconomic volatility can impact quarterly revenues and margins, especially given concentration in the U.S. market.
  • Retention of key management is crucial; loss of executives could impair performance.
  • Risks linked to acquisitions, integration, and strategic alliances may affect growth and shareholder value.

Disclaimer


The information provided in this article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with financial advisors before making investment decisions. The article is based on the Red Violet, Inc. 2025 Annual Report and is intended to highlight key points relevant to shareholders. The author does not guarantee the completeness or accuracy of the information and accepts no liability for any losses arising from reliance on this article.




View Red Violet, Inc. Historical chart here



CVR Partners, LP (UAN) 8-K SEC Filing Summary: Company Info, Trading Symbol, and Registration Details (Feb 25, 2026)

CVR Partners, LP: Notice of NYSE Non-Compliance Following Director’s Passing CVR Partners, LP Reports NYSE Non-Compliance After Sudden Director Death Key Highlights Unexpected Passing of Board Member: Brian A. Goebel, independent director and chair...

European Wax Center, Inc. 2025 Annual Report: Business Overview, Growth Strategies, Franchise Model, and Market Position

European Wax Center, Inc. 2025-2026 Annual Report – Key Highlights and Investor Insights European Wax Center, Inc. Annual Report for Fiscal Year Ended January 3, 2026: Key Highlights and Investor Implications Introduction European Wax...

Esperion Therapeutics and Corstasis Therapeutics Inc. Agreement and Plan of Merger: Key Definitions, Terms, and Transaction Details

Esperion Therapeutics, Inc. – Detailed Report Analysis (Potential Market-Moving Event) Esperion Therapeutics, Inc. (NASDAQ: ESPR) – Merger Agreement Announcement Key Points for Investors Merger Agreement Filed: Esperion Therapeutics, Inc. has filed a Form 8-K...

   Ad